UK markets open in 4 hours 33 minutes

Sartorius Stedim Biotech S.A. (0RG8.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
367.44+27.78 (+8.18%)
At close: 05:45PM GMT

Sartorius Stedim Biotech S.A.

Zone Industrielle Les Paluds
Avenue de Jouques – CS 91051 Cedex
Aubagne 13781
33 4 42 84 56 00

Full-time employees10,409

Key executives

NameTitlePayExercisedYear born
Dr. Joachim KreuzburgChairman & CEO891kN/A1965
Mr. Heiko ImöhlVP of Group Financing & Investor RelationsN/AN/AN/A
Ms. Petra KirchhoffHead of Corp. Communications & IRN/AN/A1969
Mr. John Gerard MackayExec. VP of Marketing, Sales & Services for Lab Products and Services DivisionN/AN/A1962
Benedikt OrzelekHead of Investor RelationsN/AN/AN/A
Olivier GuitardHead of Controlling BPSN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Corporate governance

Sartorius Stedim Biotech S.A.’s ISS governance QualityScore as of 1 February 2023 is 9. The pillar scores are Audit: 6; Board: 8; Shareholder rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.